see in the attached.
false
אינטרקיור בע"מ
2
380
INTERCURE LTD
Corporation no:
512051699
12810
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
20/05/2021
www.isa.gov.il
www.tase.co.il
Reference:
2021-02-028051
Time of broadcast:
14:08
14:08
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
see in the attached.
InterCure_Trade_House_final_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
04/05/2021
Address:
Medinat ha-Yehudim Street
85
,
Herzliya
4676670
Israel
,
Tel:
077-4605012
,
Fax:
09-7680244
E-mail address:
office@canndoc-pharma.com
Company site:
www.Intercure.co
Previous names of reporting entity:
Name of the Signatory:
Blumenfeld Maayan
Position of Signatory in the reporting corporation:
Legal Counsel
Name of Employer Company:
Address:
Medinat ha-Yehudim Street
85
,
Herzliya
4676670
Telephone:
077-4605012
Facsimile:
09-7680244
E-mail:
maayanb@canndoc-pharma.com
1